AU2002310674A1 - Novel nucleic acids and their therapeutic use in ophthalmology - Google Patents

Novel nucleic acids and their therapeutic use in ophthalmology

Info

Publication number: AU2002310674A1
Authority: AU; Australia
Prior art keywords: ophthalmology; nucleic acids; therapeutic use; novel nucleic; novel
Prior art date: 2001-05-22
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2002310674A

Inventor

Bettina Couderc

Francois Malecaze

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Individual

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-05-22

Filing date

2002-05-21

Publication date

2002-12-03

2002-05-21 Application filed by Individual filed Critical Individual

2002-12-03 Publication of AU2002310674A1 publication Critical patent/AU2002310674A1/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4746—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used p53
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4747—Apoptosis related proteins
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6472—Cysteine endopeptidases (3.4.22)
- C12N9/6475—Interleukin 1-beta convertase-like enzymes (3.4.22.10; 3.4.22.36; 3.4.22.63)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10341—Use of virus, viral particle or viral elements as a vector
- C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Genetics & Genomics (AREA)
Engineering & Computer Science (AREA)
Zoology (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Biomedical Technology (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Wood Science & Technology (AREA)
Medicinal Chemistry (AREA)
Biotechnology (AREA)
General Engineering & Computer Science (AREA)
Biophysics (AREA)
Microbiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Ophthalmology & Optometry (AREA)
Toxicology (AREA)
Virology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
Physics & Mathematics (AREA)
Plant Pathology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AU2002310674A 2001-05-22 2002-05-21 Novel nucleic acids and their therapeutic use in ophthalmology Abandoned AU2002310674A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
FR0106726A FR2825101B1 (en)	2001-05-22	2001-05-22	NOVEL NUCLEIC ACID MOLECULES AND THEIR THERAPEUTIC APPLICATION IN OPHTHALMOLOGY
FR01/06726		2001-05-22
PCT/FR2002/001703 WO2002094177A2 (en)	2001-05-22	2002-05-21	Novel nucleic acids and their therapeutic use in ophthalmology

Publications (1)

Publication Number	Publication Date
AU2002310674A1 true AU2002310674A1 (en)	2002-12-03

Family

ID=8863538

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2002310674A Abandoned AU2002310674A1 (en)	2001-05-22	2002-05-21	Novel nucleic acids and their therapeutic use in ophthalmology

Country Status (4)

Country	Link
EP (1)	EP1395291A2 (en)
AU (1)	AU2002310674A1 (en)
FR (1)	FR2825101B1 (en)
WO (1)	WO2002094177A2 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5110590A (en) *	1986-02-05	1992-05-05	Krumeich Jorg H	Use of a solution of alpha-chymotrypsin
AU5817299A (en) *	1998-09-10	2000-04-03	Uab Research Foundation, The	Adenoviral vector encoding pro-apoptotic bax gene and uses thereof

2001
- 2001-05-22 FR FR0106726A patent/FR2825101B1/en not_active Expired - Fee Related
2002
- 2002-05-21 WO PCT/FR2002/001703 patent/WO2002094177A2/en not_active Ceased
- 2002-05-21 EP EP02735545A patent/EP1395291A2/en not_active Withdrawn
- 2002-05-21 AU AU2002310674A patent/AU2002310674A1/en not_active Abandoned

Also Published As

Publication number	Publication date
FR2825101B1 (en)	2004-05-14
EP1395291A2 (en)	2004-03-10
WO2002094177A2 (en)	2002-11-28
WO2002094177A3 (en)	2003-12-24
FR2825101A1 (en)	2002-11-29

Publication	Publication Date	Title
AU2001293553A1 (en)	2002-04-02	Phosphatidylserine-carrying apoptosis-mimicking bodies and the use thereof in medical treatment
AU2002346504A1 (en)	2003-06-10	Therapeutic protein and treatments
AU2002258728A1 (en)	2002-10-21	Gene brcc-3 and diagnostic and therapeutic uses thereof
AU2002305151A1 (en)	2002-10-21	Gene scc-112 and diagnostic and therapeutic uses thereof
AU2002246808A1 (en)	2002-08-06	Human nucleic acids and polypeptides and methods of use thereof
AU2002303261A1 (en)	2002-10-21	Gene brcc2 and diagnostic and therapeutic uses thereof
AU2002323286A1 (en)	2003-03-03	Human toxicologically relevant genes and arrays
AU2003244455A1 (en)	2003-09-02	Piperidylcarboxamide derivatives and their use in the treatment of tachykinim-mediated diseases
AU2002303262A1 (en)	2002-10-21	Gene shinc-1 and diagnostic and therapeutic uses thereof
AU2001264955A1 (en)	2001-12-11	Human cyslt2 nucleic acids, polypeptides, and uses thereof
AU2001268053A1 (en)	2002-01-14	Human sparc-homologous (hsparc-h1) gene and methods and uses thereof
AU2001256977A1 (en)	2001-11-12	Human sez6 nucleic acids and polypeptides
AU2002310674A1 (en)	2002-12-03	Novel nucleic acids and their therapeutic use in ophthalmology
AUPR548601A0 (en)	2001-06-28	Pyrazolopyrazinecompound and pharmaceutical use thereof
AUPQ884500A0 (en)	2000-08-10	Novel therapeutic molecules and uses therefor - III
AU2002351176A1 (en)	2003-06-17	Peptides and use thereof in therapeutic agents against hiv infection
AU3364401A (en)	2001-07-03	Modified nucleic acids and their use
AU2001245693A1 (en)	2001-10-03	Human paris-1 antigen and nucleic acids: diagnostic and therapeutic uses
AU2002321141A1 (en)	2003-03-03	Pyrimidinoxyalkylpiperazines and their therapeutic use
AU2002226691A1 (en)	2002-07-30	Human apoptosis-associated genes and human apoptosis-associated proteins produced thereby
AU5760200A (en)	2001-01-09	Human genes and proteins encoded thereby
AU5309500A (en)	2000-12-28	Novel human genes and proteins encoded thereby
AU2002240094A1 (en)	2002-08-06	Anti-apoptopic gene scc-s2 and diagnostic and therapeutic uses thereof
AU2002357145A1 (en)	2003-07-09	Therapeutic protein and nucleic acid
AUPR195400A0 (en)	2001-01-04	Novel therapeutic molecules and methods relating thereto

Legal Events

Date	Code	Title	Description
2004-03-11	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase